Hendrik Eggers

Carl Neuberg Street 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Real-World Experience With Lenvatinib Plus Everolimus (LEN+EVE) in Patients With Pretreated Advanced Renal Cell Carcinoma (RELEVANCE): A Retrospective, Multicenter Case Series.

Real-World Experience With Lenvatinib Plus Everolimus (LEN+EVE) in Patients With Pretreated Advanced Renal Cell Carcinoma (RELEVANCE): A Retrospective, Multicenter Case Series.

Journal: Clinical genitourinary cancer

Published: July 17, 2025

Impact of local therapy in metastatic renal cell carcinoma during medical treatment in a retrospective analysis.

Impact of local therapy in metastatic renal cell carcinoma during medical treatment in a retrospective analysis.

Journal: Scientific reports

Published: July 04, 2024

Enfortumab vedotin as a salvage option as 5th line therapy for metastatic urothelial bladder cancer.

Enfortumab vedotin as a salvage option as 5th line therapy for metastatic urothelial bladder cancer.

Journal: Aktuelle Urologie

Published: November 14, 2023

First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely.

First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely.

Journal: Advances in therapy

Published: February 17, 2023

A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma.

A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma.

Journal: Advances in therapy

Published: February 17, 2023

Anti-EGFR-Based Therapy in Recurrent or Metastatic HNSCC - What Difference Does it Make?

Anti-EGFR-Based Therapy in Recurrent or Metastatic HNSCC - What Difference Does it Make?

Journal: Cancer investigation

Published: October 14, 2022

Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?

Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?

Journal: World journal of urology

Published: March 23, 2022

Oncologic aspects in treatment of pathologic fractures

Oncologic aspects in treatment of pathologic fractures

Journal: Der Unfallchirurg

Published: June 22, 2021

Impact of sarcopenia in advanced and metastatic soft tissue sarcoma.

Impact of sarcopenia in advanced and metastatic soft tissue sarcoma.

Journal: International journal of clinical oncology

Published: April 23, 2021

Hepatic toxicity during regorafenib treatment in patients with metastatic gastrointestinal stromal tumors.

Hepatic toxicity during regorafenib treatment in patients with metastatic gastrointestinal stromal tumors.

Journal: Molecular and clinical oncology

Published: March 04, 2020

Renal cell carcinoma in kidney transplant recipients: descriptive analysis and overview of a major German transplant center.

Renal cell carcinoma in kidney transplant recipients: descriptive analysis and overview of a major German transplant center.

Journal: Future oncology (London, England)

Published: October 31, 2019

FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia.

FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia.

Journal: British journal of haematology

Published: June 28, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026